Aandelen in “Productie”
Aandeel | Datum | Koers | Evolutie |
---|---|---|---|
V2X Inc | 2/12 | 59,590 USD
-1,10% |
-1,10% |
Vaa Vista Alegre Atlantis SGPS | 2/12 | 1,030 EUR
0,00% |
0,00% |
Valeo S.A. | 3/12 | 7,548 EUR
-2,28% |
-2,28% |
Valero Energy Corp. | 2/12 | 140,140 USD
+0,76% |
+0,76% |
Valhi, Inc. | 2/12 | 26,560 USD
+3,75% |
+3,75% |
Valmont Industries, Inc. | 2/12 | 349,270 USD
+0,41% |
+0,41% |
Van de Velde | 3/12 | 28,800 EUR
0,00% |
0,00% |
Vanda Pharmaceuticals Inc | 2/12 | 5,040 USD
-2,14% |
-2,14% |
Varex Imaging Corp | 2/12 | 16,400 USD
-1,68% |
-1,68% |
Varta AG | 3/12 | 1,750 EUR
-8,85% |
-8,85% |
Vaxart Inc | 2/12 | 0,592 USD
-1,64% |
-1,64% |
Vaxcyte Inc | 2/12 | 91,600 USD
-2,90% |
-2,90% |
Vecima Networks Inc. | 2/12 | 17,000 CAD
-1,68% |
-1,68% |
Vector Group Ltd | 4/10 | 14,990 USD
+0,20% |
+0,20% |
Vectron Systems AG. | 30/09 | 12,150 EUR
0,00% |
0,00% |
Veeco Instruments Inc | 2/12 | 29,070 USD
+4,31% |
+4,31% |
Veeva Systems Inc | 2/12 | 227,460 USD
-0,17% |
-0,17% |
Velan, Inc. | 2/12 | 10,750 CAD
-2,27% |
-2,27% |
Velocity Composites Plc | 2/12 | 22,000 GBX
-2,65% |
-2,65% |
Ventripoint Diagnostics Ltd | 2/12 | 0,090 CAD
-18,18% |
-18,18% |
Venture Life Group Plc | 2/12 | 38,500 GBX
0,00% |
0,00% |
Venus Concept Inc | 2/12 | 0,313 USD
-2,55% |
-2,55% |
Vera Bradley Inc | 2/12 | 5,940 USD
+1,54% |
+1,54% |
VERALLIA | 29/11 | 25,160 EUR
+0,32% |
+0,32% |
Verastem Inc | 2/12 | 5,520 USD
+3,37% |
+3,37% |
Verde Agritech Plc | 2/12 | 0,610 CAD
-8,96% |
-8,96% |
Vergnet | 3/12 | 0,004 EUR
-5,41% |
-5,41% |
Vericel Corp | 2/12 | 58,740 USD
+1,03% |
+1,03% |
Verimatrix | 3/12 | 0,288 EUR
-0,69% |
-0,69% |
Verona Pharma Plc | 2/12 | 39,110 USD
-1,31% |
-1,31% |
Verrica Pharmaceuticals Inc | 2/12 | 1,280 USD
0,00% |
0,00% |
Versarien Plc | 2/12 | 0,033 GBX
+3,12% |
+3,12% |
Vertex Energy Inc | 29/11 | 0,078 USD
0,00% |
0,00% |
Vertex Pharmaceuticals, Inc. | 2/12 | 465,730 USD
-0,51% |
-0,51% |
Vertiv Holdings Co | 2/12 | 127,050 USD
-0,43% |
-0,43% |
Veru Inc | 2/12 | 0,695 USD
-1,82% |
-1,82% |
Vesuvius plc | 2/12 | 418,500 GBX
+0,24% |
+0,24% |
Vetoquinol | 3/12 | 77,800 EUR
0,00% |
0,00% |
VF Corp. | 2/12 | 20,870 USD
+3,16% |
+3,16% |
Vianet Group Plc. | 2/12 | 96,250 GBX
-6,10% |
-6,10% |
Viasat, Inc. | 2/12 | 10,060 USD
+7,82% |
+7,82% |
Viavi Solutions Inc | 2/12 | 10,370 USD
+4,33% |
+4,33% |
Vicor Corp. | 2/12 | 57,690 USD
+8,42% |
+8,42% |
Victoria plc | 2/12 | 40,850 GBX
-5,11% |
-5,11% |
Viemed Healthcare Inc | 2/12 | 8,990 USD
+3,69% |
+3,69% |
Viking Therapeutics Inc | 2/12 | 51,510 USD
-2,70% |
-2,70% |
Vinco Ventures Inc | 2/12 | 0,000 USD
-50,00% |
-50,00% |
Virbac SA | 3/12 | 317,500 EUR
-0,31% |
-0,31% |
Virco Manufacturing Corp. | 2/12 | 16,650 USD
+1,40% |
+1,40% |
Virgin Galactic Holdings Inc | 2/12 | 7,020 USD
-3,84% |
-3,84% |
VirTra Inc | 2/12 | 7,720 USD
-1,40% |
-1,40% |
Viscom AG | 2/12 | 3,080 EUR
-0,96% |
-0,96% |
Vishay Intertechnology, Inc. | 2/12 | 19,410 USD
+1,62% |
+1,62% |
Vishay Precision Group Inc | 2/12 | 23,600 USD
+2,74% |
+2,74% |
Vislink Technologies Inc | 2/12 | 4,390 USD
-2,88% |
-2,88% |
Vista Outdoor Inc | 26/11 | 44,630 USD
+0,54% |
+0,54% |
VistaGen Therapeutics Inc | 2/12 | 2,830 USD
-0,35% |
-0,35% |
Visteon Corp. | 2/12 | 95,355 USD
+2,13% |
+2,13% |
Vita 34 AG | 2/12 | 4,120 EUR
0,00% |
0,00% |
Vital Farms Inc | 2/12 | 33,750 USD
+1,66% |
+1,66% |
Vitality Products | 27/11 | 0,025 CAD
+25,00% |
+25,00% |
Viveve Medical Inc | 27/11 | 0,000 USD
0,00% |
0,00% |
Volex plc | 2/12 | 288,000 GBX
-0,35% |
-0,35% |
VolitionRX Ltd | 2/12 | 0,650 USD
-6,52% |
-6,52% |
Volkswagen AG | 3/12 | 80,360 EUR
-0,37% |
-0,37% |
Volkswagen AG | 3/12 | 83,050 EUR
-0,18% |
-0,18% |
Vontier Corporation | 2/12 | 39,310 USD
+0,13% |
+0,13% |
Vossloh AG | 3/12 | 42,550 EUR
+0,47% |
+0,47% |
VOXX International Corp | 2/12 | 7,750 USD
-0,77% |
-0,77% |
Voyager Therapeutics Inc | 2/12 | 6,930 USD
+1,02% |
+1,02% |
Vranken Pommery Monopole | 3/12 | 12,650 EUR
-1,56% |
-1,56% |
vTv Therapeutics Inc | 2/12 | 15,630 USD
-2,56% |
-2,56% |
Vuzix Corporation | 2/12 | 2,530 USD
+9,52% |
+9,52% |
VYNE Therapeutics Inc | 2/12 | 2,880 USD
-2,70% |
-2,70% |